-
analytical needs, research budgeting, optimize new technology for YCGA use, and development of new technology platforms. The area of current interest in new technology platforms includes proteogenomic
-
, Endocrinology, Pharmacology, Yale Center for RNA Science and Medicine, Yale Computational Biology and Bioinformatics, as well as renowned outside institutions like the Massachusetts Institute of Technology (MIT
-
, there are multiple opportunities for translational research. Qualifications: PhD, MD or MD/PhD in neuroscience, neuroimaging, statistics, psychology, engineering or a related field is required. Previous experience
-
management. Training: Training in HLA determination by various sequencing platforms including Illumina sequencing and Nanopore technology HLA and non-HLA antibody assessments and flow cytometry to determine
-
over time? How can we develop technology that can process language effectively? By studying such topics, we can use language as a window into the human mind and human society. Overview of the Position
-
HLA associations with autoimmune/alloimmune diseases; and how to enable precise control of adaptive immune responses through engineered cellular and recombinant therapies. Available projects relate